Product catalog antigen listed by alphabetic starting with K
| Items 1 to 100 of 198 total |
2 Page(s):
|
Protein
| Catalog No. | Species | Presentation | Purity | Source | |||
|---|---|---|---|---|---|---|---|
| H00008997-Q01-10 | Kalirin antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00008997-Q01-25 | Kalirin antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003816-Q01-10 | Kallikrein-1 / KLK1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003816-Q01-25 | Kallikrein-1 / KLK1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| BA371 | Kallikrein-1 / KLK1 antigen | ||||||
| Human | Purified | >95% | Plasma | 50 µg / US$ 295 | |||
| Acris Antibodies GmbH | |||||||
| H00005655-Q01-10 | Kallikrein-10 / KLK10 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00005655-Q01-25 | Kallikrein-10 / KLK10 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000354-P01-10 | Kallikrein-3 / PSA / KLK3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000354-P01-25 | Kallikrein-3 / PSA / KLK3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| BA1022 | Kallikrein-3 / PSA / KLK3 (PSA-ACT Complex) antigen | ||||||
| Human | Purified | >95% | Seminal Fluid | 50 µg / ask | |||
| Acris Antibodies GmbH | |||||||
| BA539 | Kallikrein-3 / PSA / KLK3 antigen | ||||||
| Human | >95% | Seminal Fluid | 0.1 mg / US$ 455 | ||||
| Acris Antibodies GmbH | |||||||
| 8P78 | Kallikrein-3 / PSA / KLK3 antigen | ||||||
| Human | >98% | Seminal Fluid | 1 mg / --- | ||||
| HyTest Ltd. | |||||||
| P117-7 | Kallikrein-3 / PSA / KLK3 antigen | ||||||
| Human | >96% | Seminal Fluid | 1 mg / ask | ||||
| Scipac Ltd. | |||||||
| P192-3 | Kallikrein-3 / PSA / KLK3 antigen | ||||||
| Human | >96% | Seminal Fluid | 0.1 mg / ask | ||||
| Scipac Ltd. | |||||||
| H00025818-Q01-10 | Kallikrein-5 / KLK5 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00025818-Q01-25 | Kallikrein-5 / KLK5 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00005653-Q01-10 | Kallikrein-6 / KLK6 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00005653-Q01-25 | Kallikrein-6 / KLK6 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| LF-P0055 | Kallikrein-6 / KLK6 antigen | ||||||
| Purified | - | E. coli | 0.5 mg / --- | ||||
| Young In Frontier Co. Ltd. | |||||||
| H00011202-Q01-10 | Kallikrein-8 / KLK8 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00011202-Q01-25 | Kallikrein-8 / KLK8 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00022950-Q01-10 | Kanadaptin antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00022950-Q01-25 | Kanadaptin antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| P163-1 | Kappa Light Chain antigen | ||||||
| Human | >96% | Urine | 1 mg / ask | ||||
| Scipac Ltd. | |||||||
| P163-2 | Kappa Light Chain antigen | ||||||
| Human | Purified | >40% | Urine | 1 mg / ask | |||
| Scipac Ltd. | |||||||
| H00004986-Q01-10 | Kappa-type opioid receptor antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00004986-Q01-25 | Kappa-type opioid receptor antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| GTX78189 | Kappa-type opioid receptor - Blocking Peptide antigen | ||||||
| 20 µg / --- | |||||||
| GeneTex Inc. | |||||||
| H00011133-P01-10 | Kaptin antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00011133-P01-25 | Kaptin antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010300-P01-10 | Katanin p80 WD40-containing subunit B1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010300-P01-25 | Katanin p80 WD40-containing subunit B1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| 10-288-22331F | Katanin p80 WD40-containing subunit B1 antigen | ||||||
| Human | Purified | 95% | E. coli | 0.1 mg / --- | |||
| GenWay Biotech Inc. | |||||||
| 10-288-22331F-50 | Katanin p80 WD40-containing subunit B1 antigen | ||||||
| Human | Purified | 95% | E. coli | 50 µg / --- | |||
| GenWay Biotech Inc. | |||||||
| H00003758-Q01-10 | KCNJ1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003758-Q01-25 | KCNJ1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003766-Q01-10 | KCNJ10 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003766-Q01-25 | KCNJ10 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003768-P01-10 | KCNJ12 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003768-P01-25 | KCNJ12 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003772-P01-02 | KCNJ15 antigen | ||||||
| Human | in vitro transl. | 2 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003772-P01-10 | KCNJ15 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003772-P01-25 | KCNJ15 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003772-Q01-10 | KCNJ15 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003772-Q01-25 | KCNJ15 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003773-Q01-10 | KCNJ16 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003773-Q01-25 | KCNJ16 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003759-Q01-10 | KCNJ2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003759-Q01-25 | KCNJ2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003782-Q01-10 | KCNN-3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003782-Q01-25 | KCNN-3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003783-Q01-10 | KCNN-4 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003783-Q01-25 | KCNN-4 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009132-Q01-10 | KCNQ4 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009132-Q01-25 | KCNQ4 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002531-P01-10 | KDSR / FVT1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002531-P01-25 | KDSR / FVT1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00116138-P01-10 | Kelch domain-containing protein 3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00116138-P01-25 | Kelch domain-containing protein 3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00116138-Q01-10 | Kelch domain-containing protein 3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00116138-Q01-25 | Kelch domain-containing protein 3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00054758-P01-02 | Kelch domain-containing protein 4 antigen | ||||||
| Human | in vitro transl. | 2 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00054758-P01-10 | Kelch domain-containing protein 4 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00054758-P01-25 | Kelch domain-containing protein 4 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00025948-P01-10 | Kelch repeat and BTB domain-containing protein 2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00025948-P01-25 | Kelch repeat and BTB domain-containing protein 2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| 10-288-22280F | Kelch-like protein 12 antigen | ||||||
| Human | Purified | 95% | E. coli | 0.1 mg / --- | |||
| GenWay Biotech Inc. | |||||||
| 10-288-22280F-50 | Kelch-like protein 12 antigen | ||||||
| Human | Purified | 95% | E. coli | 50 µg / --- | |||
| GenWay Biotech Inc. | |||||||
| H00008139-Q01-10 | Kelch-like protein 16 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00008139-Q01-25 | Kelch-like protein 16 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009817-P01-10 | Kelch-like protein 19 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009817-P01-25 | Kelch-like protein 19 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00026249-Q01-10 | Kelch-like protein 3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00026249-Q01-25 | Kelch-like protein 3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00056062-Q01-10 | Kelch-like protein 4 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00056062-Q01-25 | Kelch-like protein 4 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003884-P01-10 | Keratin-33B (KRT33B) antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003884-P01-25 | Keratin-33B (KRT33B) antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003887-P01-10 | Keratin-81 (KRT81) antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003887-P01-25 | Keratin-81 (KRT81) antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| 45107P-1000 | Keratinocyte Growth Factor 2 antigen | ||||||
| Human | >97% | E. coli | 1 mg / --- | ||||
| QED Bioscience Inc. | |||||||
| 45107P-25 | Keratinocyte Growth Factor 2 antigen | ||||||
| Human | >97% | E. coli | 25 µg / --- | ||||
| QED Bioscience Inc. | |||||||
| 45107P-5 | Keratinocyte Growth Factor 2 antigen | ||||||
| Human | >97% | E. coli | 5 µg / --- | ||||
| QED Bioscience Inc. | |||||||
| H00011081-Q01-10 | Keratocan antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00011081-Q01-25 | Keratocan antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003795-P01-10 | Ketohexokinase antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003795-P01-25 | Ketohexokinase antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003795-Q01-10 | Ketohexokinase antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003795-Q01-25 | Ketohexokinase antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| 10-288-22373F | Ketohexokinase antigen | ||||||
| Human | Purified | 90% | E. coli | 0.1 mg / --- | |||
| GenWay Biotech Inc. | |||||||
| 10-288-22373F-50 | Ketohexokinase antigen | ||||||
| Human | Purified | 90% | E. coli | 50 µg / --- | |||
| GenWay Biotech Inc. | |||||||
| H00010657-Q01-10 | KHDRBS1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010657-Q01-25 | KHDRBS1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00004288-Q01-10 | Ki-67 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00004288-Q01-25 | Ki-67 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009870-Q01-10 | KIAA0317 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009870-Q01-25 | KIAA0317 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009907-P01-10 | KIAA0415 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009907-P01-25 | KIAA0415 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00022944-P01-02 | KIN antigen | ||||||
| Human | in vitro transl. | 2 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| Items 1 to 100 of 198 total |
2 Page(s):
|


